Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?
2022; European Respiratory Society; Volume: 31; Issue: 165 Linguagem: Inglês
10.1183/16000617.0138-2022
ISSN1600-0617
AutoresGurgen Harutyunyan, Rosa I. Benítez Bermejo, Varsenik Harutyunyan, Garnik Harutyunyan, Andrés Sánchez Gimeno, Artur Cherkezyan, Spartak Petrosyan, Anatoli Gnuni, Suren Soghomonyan,
Tópico(s)COVID-19 Clinical Research Studies
ResumoThe ventilation–perfusion mismatch can9t explain the high P aCO 2 – P ETCO 2 gap in the setting of COVID-19 induced hypoxaemia and cannot be considered as the sole pathophysiological basis for the treatment in the early stage of COVID-19 https://bit.ly/3BKmGxJ
Referência(s)